What is the optimum antibiotic prophylaxis in patients undergoing implantation of a left ventricular assist device?
Open Access
- 30 November 2011
- journal article
- review article
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 14 (2) , 209-214
Abstract
A best evidence topic was written according to a structured protocol. The question addressed was what the optimum antibiotic prophylaxis in patients undergoing implantation of a left ventricular assist device (LVAD) is. A total of 373 papers were found, of which 11 represented the best evidence. The authors, date, journal, study type, population, main outcome measures and results are tabulated. Eight retrospective and two prospective studies, including one randomized controlled trial (RCT), were identified. Although highly variable, the prophylactic antibiotic protocols employed in these studies generally favour the use of vancomycin, a cephalosporin, beta-lactam and quinolone, with the option of additional fluconazole and mupirocin. However, the lack of standardized definitions for infection, and variations in the choice, timing and duration of prophylactic antibiotics complicates the interpretation of reported infection rates. Driveline and pocket infections comprised the majority of infectious complications, and were principally attributed to Gram-positive organisms, such as Staphylococcus, as well as Pseudomonas species. We conclude that a beta-lactam be used for primary prophylaxis, with vancomycin where the risk of MRSA is high. Topical mupirocin and an anti-fungal are also recommended. Prophylaxis should commence prior to device insertion, and be continued into the peri- and post-operative period. Large-scale RCTs are necessary to assess the impact of different antibiotic regimens on infection within LVAD recipients.Keywords
This publication has 16 references indexed in Scilit:
- Working formulation for the standardization of definitions of infections in patients using ventricular assist devicesThe Journal of Heart and Lung Transplantation, 2011
- Infectious complications after pulsatile-flow and continuous-flow left ventricular assist device implantationThe Journal of Heart and Lung Transplantation, 2011
- Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist DeviceNew England Journal of Medicine, 2009
- Late-Onset Driveline Infections: The Achilles’ Heel of Prolonged Left Ventricular Assist Device SupportThe Annals of Thoracic Surgery, 2007
- The Society of Thoracic Surgeons Practice Guideline Series: Antibiotic Prophylaxis in Cardiac Surgery, Part I: DurationThe Annals of Thoracic Surgery, 2006
- Infection in permanent circulatory support: Experience from the REMATCH trialThe Journal of Heart and Lung Transplantation, 2004
- Towards evidence-based medicine in cardiothoracic surgery: best BETSInteractive CardioVascular and Thoracic Surgery, 2003
- Nosocomial Infections in Left Ventricular Assist Device RecipientsClinical Infectious Diseases, 2002
- Left Ventricular Assist Device Infection Is Associated With Increased Mortality but Is Not a Contraindication to TransplantationCirculation, 1997
- Infectious Complications in Left Ventricular Assist Device RecipientsClinical Infectious Diseases, 1997